Printer Friendly

The contribution of endoscopes to minimally invasive surgery.

The endoscope's contribution to minimally invasive surgery (MIS) procedures can be compared only to the achievements of catheter-driven MIS cardiovascular procedures. Where would the medical specialties of gastroenterology, orthopedics, laparoscopy, pulmonology, otolaryngology, urology and gynecology be without the endoscope? Even coronary artery bypass graft surgery, traditionally a highly invasive open procedure, now can be performed through endoscopic minimally invasive coronary bypass surgery. (1)

Many endoscopy-based procedures have moved beyond outpatient treatment facilities to physician's offices due to their flexibility (no pun intended) of use and the potential for a reduced cost per procedure of the office-based environment.

Why It's Important

Endoscope manufacturing has experienced strong revenue growth during the past five years and is forecast to continue expanding, even in the face of the U.S. recession. Since 2006, endoscope revenues are reported to have increased by a compound annual growth rate (CAGR) of 14.4 percent, reaching $1.8 billion in 2011; last year's CAGR was expected to be 7.4 percent. (2) Such robust growth rates mean that hospital and medical facility management are voting with their dollars for MIS procedures, even as other capital equipment purchases have declined.

The Trends

Capsule endoscopy is an area rich in development, and the opportunities for this type of endoscope seem endless. The next step in the development of passive capsule endoscopes used in the gastrointestinal (GI) tract is to configure them to be actively guided by the physician through the GI system. Many new technologies to provide active capsule guidance are in development using methods such as biotech adhesives or magnets. (3) Once GI physicians can control the movement of a capsule endoscope, future therapeutic applications abound.

The aging population, cancer and obesity rates are other drivers of the endoscope market. Globally, there are more than 1.2 million new cases of colorectal cancer diagnosed annually, according to the International Agency for Research on Cancer's "Globocan" project. (4) Cancer is a disease that often is diagnosed or treated with endoscopic equipment.

Gastric bypass and banding procedures for obesity increasingly are becoming popular bariatric surgical procedures, and endoscopy often is used pre- and post-operatively for bypass and banding procedures.

[GRAPHIC 2 OMITTED]

The Opportunity

How many other invasive procedures can be converted to an endoscopy based minimally invasive approach? Whitespace research is critical to new market development in the medtech world, to examine every disease state for opportunity for a minimally invasive device solution to improve outcomes.

Editor's note: Readers are invited to submit market data and trend questions to Maria Shepherd. Periodically, selected questions will be presented in this column, with answers from Maria. Send your questions to the email in her bio (below).

References:

(1.) www.umm.edu/heart/tecab.htm#ixzz26v9jVEEz. Accessed Sept. 17, 2012

(2.) IBISWorld Industry Report, Endoscope Manufacturing, August 2011

(3.) http://nanolab.me.cmu. edu/projects/capsules/

(4.) http://globocan.iarc.fr/ factsheet.asp, Accessed Sept. 17, 2012

Maria Shepherd * Data Decision Group

Maria Shepherd, founder of Data Decision Group, has 20 years of leadership experience in medical device and life-sciences marketing. Following a career including serving as vice president of marketing for Oridion Medical; director of marketing for Philips Medical; and senior management roles at Boston Scientific Inc., she founded Data Decision Group. Her firm quantitatively and qualitatively sizes opportunities, evaluates new technologies, and assesses prospective acquisitions for medtech companies. Shepherd teaches marketing and product development courses and recently was appointed to the board of the MSBiV Medtech Investment Committee. She can be reached at (617) 548-9892 and mshepherd@ ddecisiongroup.com.
Chart 1. 2011 Sales of Endoscope by Segment (2)

Capsule Endoscopes 8%

Rigid Endoscopes 24%

Flexible Endoscopes 68%

Note: Table made from pie chart.

Chart 3. Global Projections for
Endoscope Sales, 2011-20162

 Global Sales
 USD Billions

2011 $1.82
2016 $2.50

Note: Table made from bar graph.
COPYRIGHT 2012 Rodman Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

 
Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Datawatch
Author:Shepherd, Maria
Publication:Medical Product Outsourcing
Date:Oct 1, 2012
Words:636
Previous Article:Demographic changes and disposable technology help fuel GI endoscope markets in Brazil, India and China.
Next Article:Tubing's constant evolution: medical tubing has evolved to be a complex, sophisticated product combining various materials, technologies and...
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters